In a significant step forward for rare disease treatment, Quoin Pharmaceuticals announced the opening of the first clinical site for its Netherton Syndrome study. The specialty pharma and biotech focused on rare and orphan diseases is well-positioned to potentially deliver the first FDA-approved treatment for the syndrome, a rare and devastating genetic disease with no…
[Read More]
Bitfarms (BITF) shot up 17% for the day, following a couple of highlights for the company. Recently, Bitfarms released their recap for their first Analyst & Investor Day, where they shared information about the company, how it works, and the team and where they see themselves going forward. Bitfarms presented itself as a “a low-cost…
[Read More]
Biotechnology company, Oxford BioDynamics (AIM:OBD), is poised for successful commercialization of its precision medicine tests for oncology. Any seasoned investor will tell you that investing in biotechnology companies comes with an exhilarating balance of risk and reward. If a company is successful in getting its products to market, there is potential for significant investment gains….
[Read More]
SunPower (SPWR) fell around 11% today as the stock was initiated at Underweight by a Wells Fargo analyst. The reason behind the weak outlook is unsupported U.S. solar policies and a slowing housing market. “SunPower’s business is mostly direct sales, which we view as more sensitive to the economic environment given the large upfront cost…
[Read More]
Key commercial and regulatory milestones expected during the second half of 2022 In a recent interview, Shameze Rampertab, CFO of Asensus Surgical (NYSE American: ASXC), shared more of the Performance-Guided Surgery™ company’s 2022 plans and progress. Asensus developed and commercialized a robotic surgical system—the Senhance® Surgical System—to elevate the work of surgeons and provide advanced…
[Read More]
Kezar Life Sciences (KZR) soared 43% today as it has announced promising top-line data from their phase II study, called MISSION, evaluating its lead pipeline candidate in patients with active lupus nephritis (LN). LN is a type of kidney diseased caused by the autoimmune disease systemic lupus erythematosus (SLE). “The MISSION Phase 2 topline results…
[Read More]
Arizona State has plans for the metaverse, indicating a bright future for Web 3.0. According to filings made with the Patent and Trademark Office, among ASU’s innovative plans are NFTs for event tickets, artwork of campus landmarks, NFTs for sports highlights and classes in a “virtual environment.” ASU has had great success with their “digital…
[Read More]
uniQure has announced an update on their low-dose cohort in Phase I/II trial of AMT-130 Gene Therapy for the treatment of Huntington’s Disease, which has caused the stock to jump up 27% today. The treatment was generally well-tolerated with no significant safety issues. And there was a mean reduction of 53.8% of mutant HTT observed…
[Read More]
Blockchain Intelligence Group (BBKCF) soared 24% today on the heels of an announcement that they launched the industry’s first NFT explorer. The NFT explorer will be the first solution for researching the risk for NFTs, built on the QLUE data analytics platform. The core functions of the NFT explorer relied on heavy collaboration experts across…
[Read More]
Altimmune, Inc. (ALT) jumped 23% today after receiving a consensus recommendation of “Buy” from brokerage analysts. Out of seven analysts that are covering ALT, five rated the stock with a buy rating, with an average 12-month price target of $25.00. At the current stock price of around $9.00, analysts are seeing a lot of room…
[Read More]
Sunnova (NOVA) and Montgomery Green Bank have teamed up to make solar power more accessible for homeowners. Montgomery County Green Bank is a nonprofit dedicated to accelerating energy efficiency, renewable energy and clean energy investment. The partnership aims to help low-to-moderate income households in Montgomery, MD transition to affordable, clean energy solutions by going solar…
[Read More]
Shared Reserves, Not Expenses Verde Bio Holdings (OTCQB: VBHI) is a trusted oil and gas mineral acquisition and management company based in Texas with acquisition experience in every major basin in the United States. However, unlike most E&P companies, VBHI’s risk-averse approach to its business model makes for an attractive investment in the Energy sector. Verde…
[Read More]